TerrAscend (TSNDF) Change in Receivables (2021 - 2026)
TerrAscend's (TSNDF) quarterly Change in Receivables came in at -$1.1 million in Q1 2026, up 46.2% year-on-year from -$754471.1 in Q1 2025, and down 351.83% on a QoQ basis from $438000.0 in Q4 2025.
TerrAscend (TSNDF) Change in Receivables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Change in Receivables data on file, last reported at -$1.1 million in Q1 2026.
- On a quarterly basis, Change in Receivables rose 46.2% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was -$699000.0, a 113.43% decrease from a year earlier, with the FY2025 full-year figure at -$1.6 million, down 131.04% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.1 million, down from $438000.0 in the prior quarter.
- Over the last five years, Change in Receivables for TSNDF reached as high as $6.0 million in Q4 2024 and fell as low as -$3.2 million in Q3 2022.
- Historically, Change in Receivables has averaged $492117.6 across 5 years, with a median of $437000.0 in 2024.
- Across the five-year window, Change in Receivables jumped 3810.75% in 2023 and slumped 406.74% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$93000.0 in 2022, then soared by 3810.75% to $3.5 million in 2023, then surged by 73.08% to $6.0 million in 2024, then sank by 92.67% to $438000.0 in 2025, then sank by 351.83% to -$1.1 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$1.1 million in Q1 2026, $438000.0 in Q4 2025, and -$2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.10 Mn |
| Mar 31, 2026 | -1.10 Mn |
| Dec 31, 2025 | 438,000.00 |
| Dec 31, 2025 | 438,000.00 |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 2.56 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | 5.97 Mn |
| Dec 31, 2024 | 5.97 Mn |
| Sep 30, 2024 | 846,000.00 |
| Sep 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Mar 31, 2024 | -1.95 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Dec 31, 2023 | 3.45 Mn |